Table 1.
Demographics and baseline characteristics (intention-to-treat population)
| Characteristic | Methoxyflurane (N=149) |
Placebo (N=149) |
Total (N=298) |
|---|---|---|---|
| Age (years) | |||
| Mean (SD) | 29.7 (15.5) | 28.5 (16.2) | 29.1 (15.8) |
| Median (range) | 27 (12–74) | 24 (12–84) | 25 (12–84) |
| Sex | |||
| Male | 85 (57.0%) | 86 (57.7%) | 171 (57.4%) |
| Female | 64 (43.0%) | 63 (42.3%) | 127 (42.6%) |
| Race | |||
| White | 140 (94.0%) | 136 (91.3%) | 276 (92.6%) |
| Asian | 1 (0.7%) | 7 (4.7%) | 8 (2.7%) |
| Black | 3 (2.0%) | 3 (2.0%) | 6 (2.0%) |
| Other | 5 (3.4%) | 3 (2.0%) | 8 (2.7%) |
| VAS score (mm) | |||
| Mean (SD) | 64.8 (16.7) | 64.0 (16.8) | – |
| Median (range) | 67 (23–100) | 67 (10–100) | – |
N, number of patients; VAS, visual analogue scale.